Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 23, Issue 4, 2011, Pages 16-17

  Teng, Po Ren ^a,b   Lane, Hsien Yuan ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ARIPIPRAZOLE; BENZATROPINE; BROMOCRIPTINE; CREATINE KINASE; DANTROLENE; DIAZEPAM; LITHIUM; MYOGLOBIN; PALIPERIDONE; RISPERIDONE; VENLAFAXINE;

ADULT; AGITATION; CASE REPORT; CATATONIA; CHRONIC HEPATITIS; CONFUSION; CREATINE KINASE BLOOD LEVEL; DEFENSE MECHANISM; DELIRIUM; DEPRESSION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHAGIA; DYSPNEA; EXTRAPYRAMIDAL SYMPTOM; FEVER; HUMAN; HYPERHIDROSIS; HYPERTENSION; LETTER; LEUKOCYTE COUNT; MALE; MUSCLE RIGIDITY; MUSCLE STIFFNESS; MUTISM; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SCHIZOAFFECTIVE PSYCHOSIS; SIDE EFFECT; TACHYCARDIA;

EID: 84858057884     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.23.4.e16     Document Type: Letter

References (10)

1. de Leon J, Wynn G, Sandson NB: The pharmacokinetics of paliperidone versus risperidone. Psychosomatics 2010; 51:80-88.
2. Duggal HS: Possible neuroleptic malignant syndrome associated with paliperidone. J Neuropsychiatry Clin Neurosci 2007; 19:477-478.
3. Mantas C, Kalabokis G, Goulia P, et al: Possible neuroleptic malignant syndrome during paliperidone administration: a case report. J Clin Psychopharmacol 2010; 30:89-91.
4. Ananth J, Parameswaran S, Gunatilake S, et al: Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 2004; 65:464-470.
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
6. Velamoor VR, Norman RM, Caroff SN, et al: Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 1994; 182:168-173.
7. Picard LS, Lindsay S, Strawn JR, et al: Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations. Pharmacotherapy 2008; 28:530-535.
8. Strawn JR, Keck PE Jr, Caroff SN: Neuroleptic malignant syndrome. Am J Psychiatry 2007; 164:870-876.
9. Caroff SN, Mann SC: Neuroleptic malignant syndrome. Psychopharmacol Bull 1988; 24:25-29.
10. Pope HG Jr, Aizley HG, Keck PE Jr, et al: Neuroleptic malignant syndrome: long-term follow-up of 20 cases. J Clin Psychiatry 1991; 52:208-212.